[United States Statutes at Large, Volume 132, 115th Congress, 2nd Session]
[From the U.S. Government Publishing Office, www.gpo.gov]


Public Law 115-262
115th Congress

An Act


 
To amend title XVIII of the Social Security Act to prohibit Medicare
part D plans from restricting pharmacies from informing individuals
regarding the prices for certain drugs and biologicals. <>

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled, <>
SECTION 1. <> SHORT TITLE.

This Act may be cited as the ``Know the Lowest Price Act of 2018''.
SEC. 2. PROHIBITION ON LIMITING CERTAIN INFORMATION ON DRUG
PRICES.

(a) In General.--Section 1860D-4 of the Social Security Act (42
U.S.C. 1395w-104) is amended by adding at the end the following new
subsection:
``(m) Prohibition on Limiting Certain Information on Drug Prices.--A
PDP sponsor and a Medicare Advantage organization shall ensure that each
prescription drug plan or MA-PD plan offered by the sponsor or
organization does not restrict a pharmacy that dispenses a prescription
drug or biological from informing, nor penalize such pharmacy for
informing, an enrollee in such plan of any differential between the
negotiated price of, or copayment or coinsurance for, the drug or
biological to the enrollee under the plan and a lower price the
individual would pay for the drug or biological if the enrollee obtained
the drug without using any health insurance coverage.''.

[[Page 3671]]

(b) <> Effective Date.--The amendment
made by subsection (a) shall apply to plan years beginning on or after
January 1, 2020.

Approved October 10, 2018.

LEGISLATIVE HISTORY--S. 2553:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 164 (2018):
Sept. 4, considered and passed Senate.
Sept. 25, considered and passed House.
DAILY COMPILATION OF PRESIDENTIAL DOCUMENTS (2018):
Oct. 10, Presidential remarks.